Franck Morschhauser Selected Research

Franck Morschhauser Research Topics

Disease

50	Lymphoma (Lymphomas) 02/2024 - 08/2003
46	Neoplasms (Cancer) 04/2024 - 08/2003
37	Hodgkin Disease (Hodgkin's Disease) 11/2023 - 01/2003
36	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 07/2007
34	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023 - 02/2008
32	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 08/2010
26	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 04/2007
17	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2024 - 08/2011
12	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2024 - 09/2010
10	Neutropenia 01/2019 - 06/2003
8	Disease Progression 05/2019 - 02/2012
7	Infections 12/2023 - 05/2006
7	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 02/2005
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2021 - 08/2011
5	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 02/2024 - 09/2010
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2018 - 04/2006
3	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2024 - 02/2013
3	Pathologic Complete Response 01/2023 - 12/2014
3	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 08/2014
3	Fatigue 01/2020 - 01/2019
3	Febrile Neutropenia 01/2018 - 06/2015
3	Thrombocytopenia (Thrombopenia) 01/2017 - 03/2016
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2022 - 01/2014
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021 - 07/2021
2	Fever (Fevers) 01/2021 - 01/2017
2	Residual Neoplasm 01/2021 - 11/2020
2	Leukemia 11/2019 - 05/2006
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 08/2017 - 08/2011

Drug/Important Bio-Agent (IBA)

61	Rituximab (Mabthera)FDA Link 02/2024 - 01/2003
20	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 08/2003
19	obinutuzumabIBA 01/2024 - 05/2012
19	Lenalidomide (CC 5013)FDA Link 10/2022 - 09/2013
17	Prednisone (Sone)FDA LinkGeneric 02/2024 - 04/2011
16	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 04/2011
15	Vincristine (Oncovin)FDA LinkGeneric 02/2024 - 04/2007
15	Monoclonal AntibodiesIBA 01/2022 - 01/2003
9	Brentuximab VedotinIBA 02/2024 - 07/2013
7	axicabtagene ciloleucelIBA 05/2024 - 07/2021
7	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2022
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2022 - 03/2010
7	Agammaglobulinaemia Tyrosine KinaseIBA 03/2022 - 08/2014
7	ibrutinibIBA 03/2022 - 08/2014
7	ibritumomab tiuxetan (Zevalin)FDA Link 12/2014 - 07/2007
6	romidepsin (FK228)FDA Link 02/2024 - 02/2012
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2017
6	Bendamustine Hydrochloride FDA Link 11/2023 - 11/2013
6	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 04/2011
6	Yttrium-90IBA 12/2014 - 07/2007
5	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2014
5	venetoclaxIBA 11/2021 - 01/2019
5	Immunoconjugates (Immunoconjugate)IBA 01/2019 - 10/2011
4	Vinblastine (Vinblastine Sulfate)FDA Link 11/2023 - 01/2018
4	NivolumabIBA 01/2023 - 01/2017
4	polatuzumab vedotinIBA 01/2022 - 06/2015
3	Chlorambucil (Leukeran)FDA Link 02/2024 - 02/2013
3	pembrolizumabIBA 01/2023 - 11/2019
3	tisagenlecleucelIBA 10/2022 - 07/2021
3	atezolizumabIBA 01/2022 - 01/2021
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2018
3	tazemetostatIBA 01/2022 - 01/2020
3	idelalisibIBA 01/2021 - 01/2017
3	copanlisibIBA 01/2020 - 12/2017
3	Hormones (Hormone)IBA 05/2018 - 02/2010
3	CytokinesIBA 01/2018 - 05/2007
3	pixantrone (BBR 2778)IBA 04/2015 - 08/2003
2	AntibodiesIBA 01/2024 - 10/2011
2	glofitamabIBA 12/2022 - 01/2021
2	PlatinumIBA 03/2022 - 01/2022
2	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 01/2019
2	ruxolitinibIBA 01/2021 - 01/2018
2	EnzymesIBA 01/2021 - 04/2009
2	tirabrutinibIBA 01/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 02/2011
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 12/2014
2	Phosphotransferases (Kinase)IBA 12/2020 - 11/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 11/2018
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2020
2	acalabrutinibIBA 11/2019 - 01/2018
2	abexinostatIBA 01/2017 - 04/2015
2	Antineoplastic Agents (Antineoplastics)IBA 03/2016 - 04/2009
2	coltuximab ravtansineIBA 01/2016 - 01/2014
2	Melphalan (Alkeran)FDA LinkGeneric 12/2014 - 04/2011
2	InterferonsIBA 07/2013 - 12/2008
2	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2010 - 08/2003
2	veltuzumabIBA 05/2010 - 07/2009
1	Glucose (Dextrose)FDA LinkGeneric 04/2024

Therapy/Procedure

56	Therapeutics 05/2024 - 07/2007
37	Drug Therapy (Chemotherapy) 02/2024 - 02/2005
21	Stem Cell Transplantation 05/2024 - 07/2007
7	Immunotherapy 10/2021 - 07/2005
6	Cell Transplantation 01/2018 - 01/2017
6	Radioimmunotherapy 01/2014 - 07/2007
5	Transplantation 11/2019 - 04/2006
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 08/2018 - 12/2017
4	Salvage Therapy 12/2023 - 12/2008
3	Induction Chemotherapy 01/2020 - 05/2006
2	BEAM regimen 12/2014 - 04/2011
2	Intravenous Infusions 01/2014 - 09/2010
2	Autologous Transplantation 07/2013 - 08/2011